These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 641217)

  • 41. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-arrhythmic therapy with verapamil by intravenous infusion].
    Furlanello F; Piccolo E; Disertori M; Trevi GP; Lanzetta T; Miori
    Minerva Med; 1975 May; 66(39):1887-903. PubMed ID: 1128829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term therapy with disopyramide phosphate: side effects and effectiveness.
    Bauman JL; Gallastegui J; Strasberg B; Swiryn S; Hoff J; Welch WJ; Bauernfeind RA
    Am Heart J; 1986 Apr; 111(4):654-60. PubMed ID: 3082173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate effects of intravenous verapamil in cardiac arrhythmias.
    Schamroth L; Krikler DM; Garrett C
    Br Med J; 1972 Mar; 1(5801):660-2. PubMed ID: 5015294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report.
    Shimoda H; Takahashi T
    BMC Oral Health; 2019 Dec; 19(1):271. PubMed ID: 31801491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Practolol in the treatment of cardiac arrhythmias].
    Rigo P; Collignon P
    Acta Cardiol; 1972; Suppl 16():71-86. PubMed ID: 4119922
    [No Abstract]   [Full Text] [Related]  

  • 50. [3-Year experience in the treatment with several arrhythmias with ritmos (ajmalin)].
    Apostolov L; Batalov Z; Mironov P; Panitsa D
    Kardiologiia; 1968 Nov; 8(11):82-9. PubMed ID: 4184833
    [No Abstract]   [Full Text] [Related]  

  • 51. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful termination of combined rapid atrial flutter/fibrillation and ventricular tachycardia by intravenous sotalol.
    Ramsdale DR; Peterson C
    Postgrad Med J; 1987 Jul; 63(741):579-80. PubMed ID: 3658868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Mizgala HF; Huvelle PR
    J Int Med Res; 1976; 4(1 Suppl):82-5. PubMed ID: 1026535
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical use of propranolol (Inderal)].
    Doshchitsin VL; Zharov EI; Arshakuni RO
    Kardiologiia; 1967 Oct; 7(10):59-67. PubMed ID: 4179686
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 56. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of magnesium versus verapamil on supraventricular arrhythmias.
    Gullestad L; Birkeland K; Mølstad P; Høyer MM; Vanberg P; Kjekshus J
    Clin Cardiol; 1993 May; 16(5):429-34. PubMed ID: 8504578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrophysiology of disopyramide in man.
    Ross D; Vohra J; Cole P; Hunt D; Sloman G
    Aust N Z J Med; 1978 Aug; 8(4):377-83. PubMed ID: 282851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 60. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A; Malfatti S
    Minerva Med; 1975 May; 66(39):1923-31. PubMed ID: 48221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.